In this slideshow, we highlight newly released treatment recommendations for rheumatic disease patients undergoing total hip or total knee arthroplasty.
The American College of Rheumatology and the American Association of Hip and Knee Surgeons have issued guidelines for physicians and patients about the perioperative management of antirheumatic medications in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. In this slideshow, we offer a brief look at the guidelines.Â For more information about the guidelines from Rheumatology Network, please see, "New Antirheumatic Drug Guidelines for Hip and Knee Arthroplasty."Â Â
Susan M. Goodman, Bryan Springer, Gordon Guyatt, et al. "2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty," Arthritis Care & Research. Epublish ahead of print. June 16, 2017. DOI 10.1002/acr.23274